Docetaxel
DOCETAXEL 20MG 1MD Vial
DOCETAXEL 160MG 16MD Vial
DOCETAXEL 20MG 1MD Vial
About: Docetaxel (Taxotere)
Docetaxel is approved in treatment of breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer and metastatic prostate cancer.
Docetaxel is also being investigated to treat small cell lung, ovarian, bladder, and pancreatic cancers, soft tissue sarcoma and melanoma. Docetaxel is given through a vein (intravenously, IV).
There is no pill form of docetaxel.
Docetaxel belongs to a class of chemotherapy drugs called plant alkaloids. Plant alkaloids are made from plants. The plant alkaloids are cell-cycle specific meaning they attack the cells during various phases of division.
Docetaxel may also be used for purposes not listed above.
INDICATIONS
Breast Cancer
TAXOTERE is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy.
TAXOTERE in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Non-Small Cell Lung Cancer
Prostate Cancer
Gastric Adenocarcinoma
Head and Neck Cancer
TAXOTERE in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
COMMONLY PURCHASED TOGETHER
Cisplatin
Cyclophosphamide
Doxorubicin
Fluorouracil
Ondansetron
Prednisone
Palonosetron
REQUEST MORE INFO
Delivering the medication
YOU NEED
WHEN YOU NEED IT
even during periods of
shortages in the market.
